Canada markets closed

Helix BioPharma Corp. (HBP.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
0.2250-0.0200 (-8.16%)
At close: 03:21PM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 42.71M
Enterprise Value 43.71M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)42.02
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -5.56

Trading Information

Stock Price History

Beta (5Y Monthly) -0.41
52-Week Change 3-54.00%
S&P500 52-Week Change 3-15.36%
52 Week High 30.6200
52 Week Low 30.1600
50-Day Moving Average 30.2086
200-Day Moving Average 30.2330

Share Statistics

Avg Vol (3 month) 329.17k
Avg Vol (10 day) 37.37k
Shares Outstanding 5174.34M
Implied Shares Outstanding 6N/A
Float 8139.11M
% Held by Insiders 125.60%
% Held by Institutions 115.13%
Shares Short (Sept 14, 2022) 414.93k
Short Ratio (Sept 14, 2022) 40.57
Short % of Float (Sept 14, 2022) 40.01%
Short % of Shares Outstanding (Sept 14, 2022) 40.01%
Shares Short (prior month Aug 14, 2022) 494.6k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Jul 30, 2021
Most Recent Quarter (mrq)Apr 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-167.53%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -7.16M
Net Income Avi to Common (ttm)-7.95M
Diluted EPS (ttm)-0.0560
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.88M
Total Cash Per Share (mrq)0.01
Total Debt (mrq)2.88M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.69
Book Value Per Share (mrq)-0.01

Cash Flow Statement

Operating Cash Flow (ttm)-6.46M
Levered Free Cash Flow (ttm)-4.05M